To address scoring variations, the International Collaboration on Cancer Reporting (ICCR) has developed guidelines for standardised reporting of colorectal cancer biomarkers; however, CDX2 is yet to be included [35]. This evidence concerns the gene CDX2 and colorectal cancer.